Evidence map›Paper›PMID 41774777›Full record

ArticlePLoS pathogens2026

Fatal human H3N8 influenza virus has a moderate pandemic risk.

Valerie Le Sage, Michelle N Vu, Maria A Maltepes, Shengyang Wang, Brooke A Snow, Grace A Merrbach, Alexandra J Benton, Kylie E Zirckel, Sarah E Petnuch, Carly N Marble and 7 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Valerie Le SageDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Michelle N VuDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Maria A MaltepesDepartment of Biology, School of Arts and Sciences, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Shengyang WangDepartments of Molecular Medicine and Immunology & Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.
Brooke A SnowCenter for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Grace A MerrbachCenter for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Alexandra J BentonCenter for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Kylie E ZirckelCenter for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Sarah E PetnuchCenter for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Carly N MarbleCenter for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Lora H RigattiDivision of Laboratory Animal Resources, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
James C PaulsonDepartments of Molecular Medicine and Immunology & Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.
Elizabeth M DrapeauDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Anita K McElroyCenter for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Scott E HensleyDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Louise H MonclaDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Seema S LakdawalaDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America.ORCID https://orcid.org/0000-0002-7679-2150

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In China, low pathogenic avian influenza (LPAI) H3N8 virus is widespread among chickens and has recently caused three zoonotic infections, with the last one in 2023 being fatal. Here we evaluated the relative pandemic risk of this 2023 zoonotic H3N8 influenza virus, utilizing our previously published decision tree. Serological analysis indicated that a large proportion of the human population does not have any cross-neutralizing antibodies against this H3N8 strain. LPAI H3N8 displayed a dual affinity for α2-3 and α2-6 sialic acids and replicated efficiently in human bronchial epithelial cells. Furthermore, we observed H3N8 transmission via direct contact but not aerosols to ferrets with pre-existing H3N2 immunity. Although pre-existing H3N2 immunity resulted in a shortened disease course in ferrets, it did not reduce disease severity or replication in the respiratory tract. This study suggests that this zoonotic H3N8 strain has moderate pandemic potential and emphasizes the continued need for avian influenza surveillance.

Indexed as

Influenza A Virus, H3N8 SubtypeInfluenza, HumanOrthomyxoviridae InfectionsAnimalsChickensChinaFerretsHumansInfluenza A Virus, H3N2 SubtypeInfluenza in BirdsPandemicsViral ZoonosesZoonoses

Identifiers

PMID41774777
PMCPMC12970972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.